Glanbia Nutritionals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Glanbia Nutritionals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0503
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glanbia Nutritionals Inc (Glanbia Nutritionals), a subsidiary of Glanbia plc is a provider of nutritional ingredients, functional ingredients, and customized premix solutions. The company manufactures and markets customized micronutrient blends, vitamins, minerals, amino acids, colors and specialty ingredients. These products find applications in beverages, foods, supplements and cosmetics. The company caters its products to nutrition-based industries, including functional foods, infant nutrition, clinical nutrition, nutritional supplements, and animal nutrition. Glanbia has its marketing and sales network in China, Europe, the US, Asia; and manufacturing facilities in California, Missouri, Carlsbad and SpringField in the US, Germany and China. Glanbia Nutritionals is headquartered in Carlsbad, California, the US.

Glanbia Nutritionals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Nattopharma Enters into Distribution Agreement with Glanbia Nutritionals for MenaQ7 10
Nattopharma Enters into Distribution Agreement with Glanbia Nutritionals 11
ChromaDex Enters Into Distribution Agreement With Glanbia Nutritionals For pTeroPure 12
Glanbia Nutritionals Inc – Key Competitors 13
Glanbia Nutritionals Inc – Key Employees 14
Glanbia Nutritionals Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glanbia Nutritionals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nattopharma Enters into Distribution Agreement with Glanbia Nutritionals for MenaQ7 10
Nattopharma Enters into Distribution Agreement with Glanbia Nutritionals 11
ChromaDex Enters Into Distribution Agreement With Glanbia Nutritionals For pTeroPure 12
Glanbia Nutritionals Inc, Key Competitors 13
Glanbia Nutritionals Inc, Key Employees 14
Glanbia Nutritionals Inc, Other Locations 15

List of Figures
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Glanbia Nutritionals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Glanbia Nutritionals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntriCon Corp (IIN)-医療機器分野:企業M&A・提携分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products include glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support products …
  • Otis Elevator Co:企業の戦略・SWOT・財務情報
    Otis Elevator Co - Strategy, SWOT and Corporate Finance Report Summary Otis Elevator Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務情報
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Air Lease Corporation:企業の戦略・SWOT・財務分析
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lanco Infratech Ltd:企業の戦略的SWOT分析
    Lanco Infratech Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Luna Innovations Inc (LUNA):医療機器:M&Aディール及び事業提携情報
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • Protokinetix Inc (PKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • New Standard Energy Ltd (NSE):企業の財務・戦略的SWOT分析
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • American Municipal Power Inc:企業の発電所・SWOT分析2018
    American Municipal Power Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • EndoCeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline products include drugs for various indications such as endometriosis, male hypogonadism and antiandrogens, among others. It develop …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nasdaq Inc (NDAQ):企業の財務・戦略的SWOT分析
    Nasdaq Inc (NDAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ITOCHU Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    ITOCHU Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Toronto Hydro Corporation:電力:M&Aディール及び事業提携情報
    Summary Toronto Hydro Corporation (Toronto Hydro) is a municipal electricity distribution utility. It holds businesses in electricity distribution and street lighting and expressway lighting services in Toronto. The company owns and operates electricity distribution system, which delivers electricit …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆